@PeterDiamandis As an owner who will work to leverage the free energy, robots and AI to help ensure the promise of abundance makes it those who may not have benefited from the early awareness proliferated by you and your network. Thank you for Moonshots
#QuadTherapy for HFrEF
Essential, foundational, very large benefit....
But not enough to make #HFrEF a low-risk condition.
👇
https://t.co/P56nL6TvHZ
So where do additional therapies fit?
👇
https://t.co/4L2cNs0105
@gcfmd@JavedButler1
Corstasis Therapeutics is pleased to announce that Enbumyst™
(bumetanide nasal spray) is now available for pre-order
through Carepoint Pharmacy and is now searchable on most Erx platforms.
Carepoint is now accepting e-prescriptions for Enbumyst and provides nationwide dispensing services.
For full ordering instructions — including EMR search
guidance, required prescription details, NDC, quantity
options, and optional prior authorization information —
access the step-by-step Carepoint Ordering Guide here:
👉https://t.co/PxVGWEoScD
Learn more about ENBUMYST, including potential risks, at https://t.co/oGPcyWyPij
#Biotech #SpecialtyPharmacy #HealthcareOperations
#CHF #homeiswheretheheartis
@bkolskk@EricAdler17@FudimMarat@AHajduczok@Murmur_MD@dranulala@DrAmirKaki@AndrewPAmbrosy@NavinKapur4@BurkhoffMd@aidanraneymd@jefftylermd@joewalshmd@Abraham_Jacob
Corstasis Therapeutics is pleased to announce that Enbumyst™
(bumetanide nasal spray) is now available for pre-order
through Carepoint Pharmacy and is now searchable on most Erx platforms.
Carepoint is now accepting e-prescriptions for Enbumyst and provides nationwide dispensing services.
For full ordering instructions — including EMR search
guidance, required prescription details, NDC, quantity
options, and optional prior authorization information —
access the step-by-step Carepoint Ordering Guide here:
👉https://t.co/PxVGWEoScD
Learn more about ENBUMYST, including potential risks, at https://t.co/oGPcyWyPij
#Biotech #SpecialtyPharmacy #HealthcareOperations
#CHF #homeiswheretheheartis
@bkolskk@EricAdler17@FudimMarat@AHajduczok@Murmur_MD@dranulala@DrAmirKaki@AndrewPAmbrosy@NavinKapur4@BurkhoffMd@aidanraneymd@jefftylermd@joewalshmd@Abraham_Jacob
Check out our new paper out in HF Reviews where we explore alternative pathways for treatment of acute decompensated HF, including emerging treatment strategies including intranasal bumetanide.
@AndrewJSauer@UCSDCardiology@AndrewPAmbrosy
🚨 AHA 2025 | CORALreef Lipids Trial
A true game changer in lipid management.
💊 Enliciditide (MK-0616) — the first oral PCSK9 inhibitor — achieved a 57% LDL-C reduction at week 24 and −50% sustained at week 52 vs placebo (p<0.001).
👥 Phase 3 trial, 2,912 patients with ASCVD or at high risk, across 14 countries, with excellent safety profile.
👉Takeaway: efficacy and safety comparable to injectable PCSK9 inhibitors — but in a once-daily oral tablet.
☝️A new era in PCSK9 inhibition and cardiovascular prevention.
@society_eas
#AHA2025
Most Updated Global Burden of Cardiovascular Disease now out in @JACCJournals
80% (!) of CV disease burden is attributable to modifiable RFs
Top modifiable risks in 2023:
⚠️ High systolic BP
⚠️ Dietary risks
⚠️ High LDL cholesterol
⚠️ Air pollution
🔗 https://t.co/EIvzZMQQPC
🚨 A new, practical framework for evaluating the economic value of cardiovascular drugs, devices, and preventive strategies
Just published in @JACCJournals and @CircAHA
Here’s what’s new, why it matters, and how it will shape care. 🧵
#HFSA2025 plenary & open session now!! Celebrating 30 years!!!! @HFSA@JCardFail
Congratulations to award winners, outgoing president @DukeHFDoc, @NutritionHF for chairing ASM this year & so many others!
It’s #HFSA2025 time!
Celebrating 30 years of this amazing organization that brought so many of us together! @HFSA
Marvelous pre-mtg day w/@JCardFail team, packed Device Day & seeing friends & colleagues
Tomorrow 💜💜💜 for patients!!
Presenting late-breaking VITAL-HF results Sunday at @HFSA : multicenter RCT (n=178, 7 US sites) of a remote, digital GDMT titration program vs usual care over 6 months. Primary: change in HFC score; key secondaries: KCMO, dose attainment, safety. #HFSA2025
https://t.co/jyw3y0BEvJ